Companies /Healthcare

Intuitive Surgical Inc

NASDAQ: ISRG Medical Instruments & Supplies
$416.61
▼ $5.45 (−1.29%) today
Markets open · 2:32pm ET

24/7 Wall St. View

ISRG at a Glance

Valuation
Market cap
$149.1B
P/E ratio
48.4
Profitability
Revenue (TTM)
$11.0B
Profit margin
28.4%
EPS (TTM)
$8.72
Price
52-week range
$329 – $604
24/7 target
$512.30
Street target
$478.10
Earnings
Next report
Oct 20, 2026
Q2 2026 EPS
$2.80
vs. $2.50 est.
+11.8%

Headquartered in Sunnyvale, CA Fiscal year ends December NASDAQ: ISRG intuitive.com

About Intuitive Surgical

Intuitive Surgical (Nasdaq: ISRG) is a global technology company specializing in minimally invasive care and robotic-assisted surgery. Its flagship products include the da Vinci surgical systems, used across a wide range of surgical specialties, and the Ion endoluminal system for minimally invasive lung biopsies. The company generates revenue through system placements (including sales and operating leases), recurring instruments and accessories consumed during procedures, and services including training, maintenance, and digital solutions. As of Q2 2026, Intuitive had an installed base of 11,710 da Vinci systems and 1,096 Ion systems worldwide. The company operates a joint venture with Shanghai Fosun Pharmaceutical in China and recently acquired its distribution businesses in Italy, Spain, and Portugal to transition to a direct sales model. Intuitive manufactures a significant majority of its instruments and accessories in Mexico and most of its endoscopes in Germany. Updated

Revenue by Segment · Q2 2026
  1. Instruments and Accessories60%
  2. Systems24%
  3. Services16%

Latest Activity

Mad Money w/ Jim Cramer 10/5/26

  • Cramer flags a broken pattern: oil fell while the 30-year yield climbed to 5.66%, near 6%
  • Nasdaq's record close carried by Microsoft on Copilot, Meta's small-business ad shift, and Nvidia's all-time high
  • Saudis discounting crude $5 below the Oman/Dubai benchmark is market share defense, not a fading war premium
  • Caller questions on Intuitive Surgical as a broken stock, plus KLA, Domino's and SoFi

Cramer's warning: strip out Microsoft, Nvidia and Meta and the safety names were hit, meaning three stocks are carrying the index. He says the bond market tells the truth longer term, and the 30-year at 5.66% caps any broad rally. Owning the hyperscalers has been the only trade that worked.

ISRGIntuitive Surgical
Regular session
$406.18
+4.20%open $389.80

A 4.2% intraday run to $406.18 adds roughly $6 billion to a $145 billion medtech name that rarely moves this hard in a single session. Whether it holds into the close is the tell.

ISRG Coverage

Frequently Asked Questions

What does Intuitive Surgical do?

Intuitive Surgical (Nasdaq: ISRG) is a global technology company specializing in minimally invasive care and robotic-assisted surgery. Its flagship products include the da Vinci surgical systems, used across a wide range of surgical specialties, and the Ion endoluminal system for minimally invasive lung biopsies.

What is the ISRG stock price target?

24/7 Wall St.'s 12-month price target for ISRG is $512.30, rated Buy. The Wall Street consensus target is $478.10. ISRG price prediction →